Erste Asset Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$712K Hold
35,142
0.01% 479
2026
Q1
$745K Hold
35,142
0.01% 467
2025
Q4
$420K Hold
35,142
﹤0.01% 518
2025
Q3
$548K Hold
35,142
0.01% 468
2025
Q2
$412K Hold
35,142
﹤0.01% 660
2025
Q1
$482K Hold
35,142
0.01% 432
2024
Q4
$598K Hold
35,142
0.01% 426
2024
Q3
$728K Hold
35,142
0.01% 404
2024
Q2
$811K Hold
35,142
0.01% 392
2024
Q1
$1.01M Sell
35,142
-13,723
-28% -$391K 0.01% 366
2023
Q4
$1.57M Buy
48,865
+2,199
+5% +$59.7K 0.02% 322
2023
Q3
$1.3M Buy
46,666
+681
+1% +$23.4K 0.02% 315
2023
Q2
$1.65M Buy
45,985
+8,377
+22% +$256K 0.03% 301
2023
Q1
$1.11M Buy
37,608
+5,312
+16% +$175K 0.02% 350
2022
Q4
$997K Buy
32,296
+4,606
+17% +$138K 0.02% 357
2022
Q3
$670K Buy
27,690
+3,112
+13% +$103K 0.02% 389
2022
Q2
$780K Buy
24,578
+3,142
+15% +$116K 0.02% 384
2022
Q1
$691K Buy
21,436
+9,959
+87% +$312K 0.01% 401
2021
Q4
$381K Buy
+11,477
New +$358K 0.01% 445

Other funds holding CC

Erste Asset Management's CC Position: Q2 2026 in Review

Erste Asset Management held its Chemours (CC) position steady in Q2 2026 at 35,142 shares worth $712K. The position accounts for 0.01% of the portfolio, ranked #479.

Erste Asset Management first reported a position in CC in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.65M in Q2 2023. 469 funds tracked by Wall St. Rank hold CC as of Q2 2026.

  • Erste Asset Management held 35,142 shares of Chemours worth $712K as of Q2 2026.
  • Erste Asset Management left its Chemours share count unchanged in Q2 2026.
  • Chemours made up 0.01% of Erste Asset Management's portfolio in Q2 2026, its #479 holding.
  • Erste Asset Management first reported a position in Chemours in Q4 2021 and has held it in 19 quarters since.
  • Erste Asset Management's Chemours position peaked at $1.65M in Q2 2023.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q2 2026.

Based on Erste Asset Management's 13F filing for Q2 2026, filed 28 Jul 2026.